International Clinical Trial: Use of Volta Medical AI-software During Atrial Fibrillation Ablation to Identify Patients Who May Need More Than Pulmonary Vein Isolation

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07807423) titled 'Use of Volta Medical AI-software During Atrial Fibrillation Ablation to Identify Patients Who May Need More Than Pulmonary Vein Isolation' on Sept. 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Volta Medical

Condition: Atrial Fibrillation

Intervention: Device: Complete biatrial mapping

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: September 2026

Target Sample Size: 125

Countries of Recruitment: France

To know more, visit https://clinicaltrials...